Optima Health reports 17% revenue growth in H1 F2026

Published 03/11/2025, 08:56
© Reuters.

Investing.com -- Optima Health (LSE:OPT) on Monday reported revenue of approximately £59 million for the first half of fiscal 2026, representing a 17% year-over-year increase from £50.8 million in the same period last year.

The company remains on track to deliver results in line with consensus forecasts for fiscal 2026, with full-year revenue expectations of £125.4 million.

Optima Health completed two acquisitions during the first half of the year. In April, the company acquired Cognate Health for €9 million, expanding its reach into Ireland and international markets.

Cognate Health, which has approximately 30 clinic sites, was rebranded as Optima Health Ireland in September and is expected to contribute £6-7 million in annualized revenue.

The second acquisition was Care First in May 2025 for a net consideration of £15,000, adding additional Employee Assistance Programs to Optima’s platform and approximately £3.7 million in annual revenue.

New business wins for the period amounted to approximately £1.9 million on an annualized basis, down from £3.6 million in the first half of fiscal 2025.

Mobilization on Optima Health’s £210 million contract to deliver medical assessment services to the UK Armed Forces began around April 2025, with new services expected to be in place by early 2027.

The company’s financial position shows net debt of approximately £4.7 million, with cash reserves of £8.3 million.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.